{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:15:23Z","timestamp":1790291723897,"version":"4.1.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.3109\/10428190903440946","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T15:34:47Z","timestamp":1276875287000},"page":"228-235","source":"Crossref","is-referenced-by-count":104,"title":["A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia"],"prefix":"10.1080","volume":"51","author":[{"given":"Richard R.","family":"Furman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Forero-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Shustov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Drachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0010"},{"key":"CIT0002","volume-title":"SEER Cancer Statistics Review, 1975\u20132005","author":"National Cancer Institute","year":"2008"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-7920-6_6"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-004-0060-z"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0796"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.051"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701573257"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012143432402"},{"key":"CIT0009","first-page":"317","volume":"84","author":"Stelitano C","year":"1999","journal-title":"Haematologica"},{"key":"CIT0010","first-page":"1165","volume":"86","author":"Liso V","year":"2001","journal-title":"Haematologica"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9098"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0050-z"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1326"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V112.11.325.325","volume":"112","author":"Hallek M","year":"2008","journal-title":"Blood"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.516"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700527"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0095"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh213"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008375931236"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"Cheson BD","year":"1996","journal-title":"Blood"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"365s","DOI":"10.1182\/blood.V108.11.365.365","volume":"108","author":"Hussein MA","year":"2006","journal-title":"Blood"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109097758"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4508"},{"key":"CIT0024","unstructured":"Rituxan (Rituximab) prescribing information. 2008. Available from: http:\/\/www.rituxan.com\/. Accessed 20 September 2008."},{"key":"CIT0025","unstructured":"Alemtuzumab (Campath) prescribing information. 2008. Available from: http:\/\/www.fda.gov\/CDER\/foi\/label\/2001\/alemmil050701LB.htm. Accessed 17 December 2008."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4087"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.153.2.666","volume":"153","author":"Yellin MJ","year":"1994","journal-title":"J Immunol"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0494"},{"key":"CIT0029","first-page":"120","volume":"41","author":"Bourcier T","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"723a","DOI":"10.1182\/blood.V106.11.723.723","volume":"106","author":"Hussein MA","year":"2005","journal-title":"Blood"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3017"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428190903440946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T02:35:11Z","timestamp":1740191711000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428190903440946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,12,28]]},"published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.3109\/10428190903440946"],"URL":"https:\/\/doi.org\/10.3109\/10428190903440946","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}